{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T04:53:02Z","timestamp":1758862382643,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1175567"],"award-info":[{"award-number":["GNT1175567"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in Australia and its recent increase mirrors the obesity and type 2 diabetes epidemics. Currently, many patients who present to primary care with abnormal liver function tests or steatosis on liver ultrasound are referred for assessment in secondary care. Due to the large number of patients with NAFLD, this results in long waits for clinical and fibrosis assessment, placing unnecessary burden on the public hospital system.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We will conduct a 1:1 parallel randomised trial to compare two alternative models of care for NAFLD. Participants will be randomised to usual care or the LOCal Assessment and Triage Evaluation (LOCATE) model of care and followed for 1 year. We will recruit patients from the non-neighbouring Sunshine Coast and Metro South Hospital and Health Services (HHSs) in Queensland, Australia. Our primary outcome of interest is time to diagnosis of high-risk NAFLD, based on the number of participants in each arm of the study who receive a diagnosis of clinically significant fibrosis. Two hundred and 34 participants will give us a 95% power to detect a 50% reduction in the primary outcome of time to diagnosis of high-risk disease. We will also conduct an economic evaluation, evaluating the cost-effectiveness of the new model of care. We will also evaluate the implementation of the new model of care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>It is anticipated that the results of this study will provide valuable new information regarding the management of NAFLD in the Australian setting. A relatively simple change to care could result in earlier identification of patients with significant liver disease and lower overall costs for the health system. Results will be directly disseminated to key staff for further distribution to consumers, policy- and decision-makers in the form of evidence briefs, plain language summaries and policy recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The trial was registered on 30 January, 2020 and can be found via ANZCTR - number <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=378779&amp;isReview=true\">ACTRN12620000158965<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-020-05233-2","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T06:02:30Z","timestamp":1587448950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD)"],"prefix":"10.1186","volume":"20","author":[{"given":"David","family":"Brain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"O\u2019Beirne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth E.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia C.","family":"Valery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeewa","family":"Kularatna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Tulleners","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Farrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh","family":"Horsfall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"5233_CR1","doi-asserted-by":"crossref","unstructured":"Calzadilla Bertot L, Adams AL. The Natural Course of Non-Alcoholic Fatty Liver Disease. Int J Mol Sci. 2016;17(5).","DOI":"10.3390\/ijms17050774"},{"key":"5233_CR2","first-page":"444","volume":"42","author":"D Iser","year":"2013","unstructured":"Iser D, Ryan M. Fatty liver disease a practical guide for GPs. Aust Fam Physician. 2013;42:444\u20137.","journal-title":"Aust Fam Physician"},{"issue":"S1","key":"5233_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jgh.14270","volume":"33","author":"SE Mahady","year":"2018","unstructured":"Mahady SE, Adams LA. Burden of non-alcoholic fatty liver disease in Australia. J Gastroenterol Hepatol. 2018;33(S1):1\u201311.","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"5233_CR4","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1111\/liv.13481","volume":"37","author":"D Roulot","year":"2017","unstructured":"Roulot D, Roudot-Thoraval F, NKontchou G, Kouacou N, Costes J-L, Elourimi G, et al. Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan. Liver Int. 2017;37(12):1897\u2013906.","journal-title":"Liver Int"},{"issue":"1","key":"5233_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/hep.27981","volume":"63","author":"EM Koehler","year":"2016","unstructured":"Koehler EM, Plompen EPC, Schouten JNL, Hansen BE, Darwish Murad S, Taimr P, et al. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: the Rotterdam study. Hepatology. 2016;63(1):138\u201347.","journal-title":"Hepatology"},{"issue":"2","key":"5233_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/imj.13667","volume":"48","author":"PJ Patel","year":"2018","unstructured":"Patel PJ, Banh X, Horsfall LU, Hayward KL, Hossain F, Johnson T, et al. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis. Intern Med J. 2018;48(2):144\u201351.","journal-title":"Intern Med J"},{"issue":"8","key":"5233_CR7","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hep4.1208","volume":"2","author":"P Patel","year":"2018","unstructured":"Patel P, Hossain F, Horsfall LU, Banh X, Hayward KL, Williams S, et al. A pragmatic approach identifies a high rate of nonalcoholic fatty liver disease with advanced fibrosis in diabetes clinics and at-risk populations in primary care. Hepatol Commun. 2018;2(8):897\u2013909.","journal-title":"Hepatol Commun"},{"issue":"12","key":"5233_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s40273-015-0316-5","volume":"33","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Henry L. Economic and quality-of-life implications of non-alcoholic fatty liver disease. PharmacoEconomics. 2015;33(12):1245\u201353.","journal-title":"PharmacoEconomics"},{"key":"5233_CR9","unstructured":"The Gastroenterological Society of Australia\/Australian Liver Association. The economic cost and health burden of liver diseases in Australia, Deloitte Access Economics. 2013."},{"issue":"4","key":"5233_CR10","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/imj.13008","volume":"46","author":"NA El-Atem","year":"2016","unstructured":"El-Atem NA, Wojcik K, Horsfall L, Irvine KM, Johnson T, McPhail SM, et al. Patterns of service utilisation within Australian hepatology clinics: high prevalence of advanced liver disease. Intern Med J. 2016;46(4):420\u20136.","journal-title":"Intern Med J"},{"issue":"11","key":"5233_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/jama.297.11.1233","volume":"297","author":"HGC Van Spall","year":"2007","unstructured":"Van Spall HGC, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical JournalsA systematic sampling review. JAMA. 2007;297(11):1233\u201340.","journal-title":"JAMA"},{"issue":"8","key":"5233_CR12","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jdiacomp.2018.05.008","volume":"32","author":"PJ Patel","year":"2018","unstructured":"Patel PJ, Hossain F, Horsfall LU, Banh X, Hayward KL, Williams S, et al. Controlled attenuation parameter in NAFLD identifies risk of suboptimal glycaemic and metabolic control. J Diabetes Complicat. 2018;32(8):799\u2013804.","journal-title":"J Diabetes Complicat"},{"issue":"6","key":"5233_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","volume":"88","author":"JB Saunders","year":"1993","unstructured":"Saunders JB, Aasland OG, Babor TF, De La Fuente JR, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791\u2013804.","journal-title":"Addiction"},{"issue":"12","key":"5233_CR14","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/hec.901","volume":"13","author":"G Richardson","year":"2004","unstructured":"Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ. 2004;13(12):1203\u201310.","journal-title":"Health Econ"},{"issue":"2","key":"5233_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"5233_CR16","doi-asserted-by":"crossref","unstructured":"Kropko J, Harden JJ. coxed: Duration-Based Quantities of Interest for the Cox Proportional Hazards Model [Internet]. 2019. Available from: https:\/\/CRAN.R-project.org\/package=coxed.","DOI":"10.32614\/RJ-2019-042"},{"issue":"3","key":"5233_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1053\/j.seminhematol.2008.04.003","volume":"45","author":"S Goodman","year":"2008","unstructured":"Goodman S. A dirty dozen: twelve p-value misconceptions. Semin Hematol. 2008;45(3):135\u201340.","journal-title":"Semin Hematol"},{"key":"5233_CR18","doi-asserted-by":"publisher","first-page":"h681","DOI":"10.1136\/bmj.h681","volume":"350","author":"P Sedgwick","year":"2015","unstructured":"Sedgwick P. Intention to treat analysis versus per protocol analysis of trial data. BMJ. 2015;350:h681.","journal-title":"BMJ"},{"issue":"1","key":"5233_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/ije\/dyh299","volume":"34","author":"AG Barnett","year":"2004","unstructured":"Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol. 2004;34(1):215\u201320.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"5233_CR20","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/EDE.0000000000000192","volume":"26","author":"B Lepage","year":"2015","unstructured":"Lepage B, Lamy S, Dedieu D, Savy N, Lang T. Estimating the causal effect of an exposure on change from baseline using directed acyclic graphs and path analysis. Epidemiology. 2015;26(1):122\u20139.","journal-title":"Epidemiology"},{"key":"5233_CR21","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.","journal-title":"BMJ"},{"key":"5233_CR22","doi-asserted-by":"crossref","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.","journal-title":"BMJ"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05233-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-020-05233-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-020-05233-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:23:40Z","timestamp":1618964620000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-020-05233-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5233"],"URL":"https:\/\/doi.org\/10.1186\/s12913-020-05233-2","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was granted by the Royal Brisbane Women\u2019sHospital Human Research Ethics Committee, reference number HREC\/2020\/QRBW\/60855.Participant consent will be obtained in writing.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable \u2013 no individual-level analyses will be undertaken.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}